ID1000125107
ID1000125107
Kalbe Farma Tbk
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 35.52T EUR | 34.62T EUR | 43.89T EUR | 54.57T EUR |
Enterprise Value | 32.8T EUR | 30.61T EUR | 39.8T EUR | 50.54T EUR |
Valuation Multiples | ||||
Trailing P/E | 9.89x | 11.72x | 14.82x | 18.14x |
Forward P/E | 10.49x | -- | -- | -- |
Price to Sales | 0.94x | 1.2x | 1.61x | 2.07x |
Price to Book | 1.46x | 1.42x | 1.81x | 2.34x |
EV/Revenue | 0.87x | 1.06x | 1.46x | 1.92x |
EV/EBITDA | 6.5x | 7.49x | 9.65x | 12.03x |
Price to FCF (P/FCF) | 17.91x | 20.82x | 25.32x | 29.82x |
EV/FCF | 16.53x | 18.41x | 22.96x | 27.61x |
FCF Yield | 5.58% | 4.8% | 3.95% | 3.35% |